medigraphic.com
ISSN 1561-3038 (Print)

2021, Number 1

<< Back Next >>

Rev Cubana Med Gen Integr 2021; 37 (1)

Benign prostatic hyperplasia and lower urinary tract symptoms

Conchado-Martínez J, Alvarez-Ochoa R, Serrano GC

Language: Spanish
References: 35
Page: 1-14
PDF size: 524.63 Kb.


ABSTRACT

Introduction: Benign prostatic hyperplasia constitutes a first-level healthcare concern, due to its high prevalence among men.
Objective: To identify the presence of lower urinary tract symptoms related to benign prostatic hyperplasia and its impact on the quality of life of men aged 50 years or older, without a previous diagnosis of benign prostatic hyperplasia, who attended the health center of Javier Loyola Parish.
Methods: Cross-sectional descriptive study carried out between November 2018 and January 2019, which included all the patients (106) who attended the health center of Javier Loyola Parish and agreed to complete the International Prostate Symptom Scale. The data were analyzed using descriptive statistics and the chi-square test.
Results: 35.3% of the participants belonged to the age group from 40 to 50 years. The presence was observed of mild (38.8%), moderate (39.7%) and severe (21.5%) lower urinary tract symptoms. There was a prevalence of unemployed (22.4%), bricklayers (23.3%), hypertensive (26.7%), diabetic (17.2%) and obese (14.7%) participants. The severity of the lower urinary tract symptoms was not significantly associated with the type of occupation. 61.2% of patients had mild or severe lower urinary tract symptoms and 56.8% perceived that their quality of life was affected, in some way, by lower urinary tract symptoms.
Conclusions: There is concern about the high percentage of participants with mild or severe lower urinary tract symptoms, without a previous diagnosis of benign prostatic hyperplasia, and with some perception that their quality of life is affected is. The severity of lower urinary tract symptoms increased with age but not with other factors, except occupation.


REFERENCES

  1. Chughtai B, Forde JC, Marie Thomas DD, Laor L, Hossack T, Woo HH, et al. Benign prostatic hyperplasia. Nat Rev Dis Prim. 2016 [acceso: 14/05/2020];2(1):1-15. Disponible en: https://www.nature.com/articles/nrdp201631

  2. Lim K Bin. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017 [acceso: 14/05/2020];4(3):148-51. Disponible en: https://www.sciencedirect.com/science/article/pii/S2214388217300553

  3. Kim EH, Larson JA, Andriole GL. Management of Benign Prostatic Hyperplasia. Annu Rev Med. 2016 [acceso: 14/05/2020];67(1):137-51. Disponible en: http://www.annualreviews.org/doi/10.1146/annurev-med-063014-123902

  4. Foster HE, Barry MJ, Dahm P, Gandhi MC, Kaplan SA, Kohler TS, et al. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J Urol. 2018 [acceso: 14/05/2020];200(3):612-9. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0022534718432016

  5. Sánchez Gaitán R. Hiperplasia prostatica benigna(HPB). Rev Médica Sinerg. 2016 [acceso: 14/05/2020];1(7):3-9. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/36/40

  6. Delgado-Quiñones EG, Pulido-Guerrero C, Navarro-Sandoval C, Rivera-Valdivia WG, Sahagún-Cuevas MN. Prevalencia de síntomas prostáticos en pacientes mayores de 60 años en una unidad de medicina familiar. Rev Medica MD. 2015 [acceso: 10/09/2019];6(4):263-8. Disponible en: https://go.galegroup.com/ps/anonymous?id=GALE%7CA431618355&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=20078188&p=AONE&sw=w

  7. Egan KB. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms. Urol Clin North Am. 2016 [acceso: 10/09/2019];43(3):289-97. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0094014316300027

  8. Gudmundsson J, Sigurdsson JK, Stefansdottir L, Agnarsson BA, Isaksson HJ, Stefansson OA, et al. Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA. Nat Commun. 2018 [acceso: 14/05/2020];9(1):1-8. Disponible en: https://www.nature.com/articles/s41467-018-06920-9

  9. Barboza Hernández M. HIPERPLASIA PROSTÁTICA BENIGNA. Rev Médica Sinerg. 2017 [acceso: 10/09/2019];2(8):11-6. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/91/191

  10. Yadav M, Desai H, Goswami H. Study of Various Histopathological Patterns in Prostate Biopsy. Int J Cur Res Rev. 2017 [acceso: 14/05/2020];9(21):58-63. Disponible en: https://www.ijcrr.com/uploads/2361_pdf.pdf

  11. Brenes Bermúdez FJ, Brotons Muntó F, Castiñeiras Fernández J, Cozar Olmo JM, Fernández-Pro Ledesma A, Martín Jiménez JA, et al. Documento de consenso sobre pautas de actuación y seguimiento del varón con síntomas del tracto urinario inferior secundarios a hiperplasia prostática benigna. Med Gen y Fam. 2016 [acceso: 10/09/2019];5(3):97-106. Disponible en: https://www.sciencedirect.com/science/article/pii/S188954331630010X

  12. Lorente I, Carretero M. Hiperplasia benigna de próstata: abordaje integral. Boletín Farmacoter Castilla La Mancha. 2018 [acceso: 10/09/2019];19(3):1-7. Disponible en: https://sescam.castillalamancha.es/sites/sescam.castillalamancha.es/files/documentos/farmacia/bft_3_2018.pdf

  13. Vergara Méndez V, Bautista-Samperio L. Severidad de sintomatología prostática: encuesta de pacientes entre 40-60 años. Rev Fac Med UNAM. 2007 [acceso: 10/09/2019];50(4):162-4. Disponible en: https://www.medspain.com/ant/n

  14. Orbe Montenegro VE, Vaca Yánez AR. Validación del cuestionario IISP (Índice Internacional de Síntomas Prostáticos) en pacientes con hiperplasia prostática benigna, que acuden a consulta externa del servicio de urología del Hospital Eugenio Espejo durante el periodo de abril a mayo del 2012 en la ciudad de Quito. Pontificia Universidad Católica del Ecuador. Pontificia Universidad Católica del Ecuador; 2012 [acceso: 10/09/2019]. Disponible en: http://repositorio.puce.edu.ec/handle/22000/7301

  15. Preciado-Estrella DA, Kaplan SA, Iturriaga-Goyón E, Ramón-Trejo E, Mayorga-Gómez E, Auza-Benavides A. Comparación del Índice Internacional de Síntomas Prostáticos versus Escala Visual Análoga Gea ® para la evaluación de los síntomas de la vía urinaria inferior. Rev Mex Urol. 2017 [acceso: 14/05/2020];77(5):372-82. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDREVISTA=85&IDARTICULO=75710&IDPUBLICACION=7344

  16. Yazdi H, Restrepo C, Foltz C, Hammad M, Chung PH, Gomella LG, et al. Symptomatic Benign Prostatic Hyperplasia. J Bone Jt Surg. 2020 [acceso: 14/05/2020];102(7):543-9. Disponible en: https://journals.lww.com/jbjsjournal/Abstract/2020/04010/Symptomatic_Benign_Prostatic_Hyperplasia__A_Risk.1.aspx

  17. Carrero-López VM, Cózar-Olmo JM, Miñana-López B. Hiperplasia prostática benigna y síntomas del tracto urinario inferior. Revisión de las evidencias actuales. Actas Urológicas Españolas. 2016 [acceso: 10/09/2019];40(5):288-94. Disponible en: https://www.sciencedirect.com/science/article/pii/S0210480616000036

  18. Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. The Canadian Journal of Urology TM : International Supplement. Boston, Massachusetts; 2015 [acceso: 10/09/2019]. Disponible en: https://www.canjurol.com/html/free-articles/JUV22I5S1F_06_DrLoughlin.pdf

  19. Lim K Bin. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017 [acceso: 10/09/2019];4(3):148-51. Disponible en: https://www.sciencedirect.com/science/article/pii/S2214388217300553

  20. Vignozzi L, Gacci M, Maggi M. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol. 2016 [acceso: 10/09/2019];13(2):108-19. Disponible en: http://www.nature.com/articles/nrurol.2015.301

  21. Posligua Galiano D, Barrera Pinos CE. Correlación entre el índice de masa corporal con la severidad de los síntomas del tracto urinario inferior en los pacientes de la consulta externa de Urología de los Hospitales San Francisco y Carlos Andrade Marín en el 2016. Universidad Central del Ecuador. Instituto Superior de Investigación y Postgrado de Urología; 2017 [acceso: 23/09/2019]. Disponible en: http://www.dspace.uce.edu.ec/handle/25000/10466

  22. Salman M, Khan AH, Sulaiman SAS, Hughes J, Khan JH, Hussain K. The modified urdu version of international prostate symptom score: A psychometric validation study. Turkish J Urol. 2018 [acceso: 14/05/2020];44(4):335-40. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016668/

  23. Arshad Z, Zafar Zaidi S, Jamshaid A. Introduction Development, validity and reliability of an URDU version of the International Prostate Symptom Score. 2018 [acceso: 14/05/2020];68(2):200-2. Disponible en: https://mail.jpma.org.pk/PdfDownload/8554

  24. Blanker MH, Alma HJ, Devji TS, Roelofs M, Steffens MG, Van Der Worp H. Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: Results from an observational cohort study in Dutch primary care. BMJ Open. 2019 [acceso: 14/05/2020];9(12):e032795. Disponible en: https://bmjopen.bmj.com/content/9/12/e032795.abstract

  25. Martínez Villavicencio L, González Rojas A, Olazábal Méndez J, Pardo Yero H. Diagnóstico y tratamiento de la hiperplasia prostática benigna | Martínez Villavicencio | Progaleno. Progaleno. 2018 [acceso: 14/05/2020];1(2):133-47. Disponible en: http://www.revprogaleno.sld.cu/index.php/progaleno/article/view/25

  26. Rubinstein E, Gueglio G, Giudice C, Tesolín P. Actualización: Hiperplasia prostática benigna. Evid Act Pr Ambul. 2013 [acceso: 23/09/2019];16(4):143-51. Disponible en: https://www.fundacionmf.org.ar/files/e820ed0fa2e6f7e75ffdb077dd4373e3.pdf

  27. King-ho Wong C, Pui-Hang Choi E, Wai-Hee Chan S, Hok-leung Tsu J, Chi-wai F, Sau-kwan Chu P, et al. Use of the International Prostate Symptom Score (IPSS) in Chinese male patients with benign prostatic hyperplasia. Aging Male. 2017 [acceso: 23/09/2019];20(4):241-9. Disponible en: https://www.tandfonline.com/doi/full/10.1080/13685538.2017.1362380

  28. Raza I, Kamran M, Shaheen S. Grading Of Prostate Volume And International Prostatic Symptom Score (IPSS) In A Subset Of Karachi Population. JBUMDC. 2019 [acceso: 23/09/2019];9(1):30-3. Disponible en: http://111.68.99.22:8080/xmlui/bitstream/handle/123456789/8199/GradingOfProstateVolumeAndInternationalProstaticSymptomScore%28IPSS%29.pdf?sequence=1&isAllowed=y

  29. Chicharro-Molero JA, Burgos-Rodriguez R, Sanchez-Cruz JJ, Del Rosal-Samaniego JM, Rodero-Carcia P, Rodriguez-Vallejo JM. Prevalence of benign prostatic hyperplasia in Spanish men 40 years old or older. J Urol. 1998 [acceso: 23/09/2019];159(3):878-82. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/9474174

  30. Hunter D, Berra-Unamuno A, Martin-Gordo A. Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older. - PubMed - NCBI. J Urol. 1996 [acceso: 23/09/2019];155(6):1965-70. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/8618298

  31. Tsukamoto T, Kumamoto Y, Masumori N, Miyake H, Rhodes T, Girman CJ, et al. Prevalence of Prostatism in Japanese Men in a Community-based Study with Comparison to a Similar American Study. J Urol. 1995 [acceso: 10/09/2019];154(2 Pt 1):391-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/7541852

  32. Haidinger G, Madersbacher S, Waldhoer T, Lunglmayr G, Vutuc C. The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables.1. Haidinger G, Madersbacher S, Waldhoer T, Lunglmayr G, Vutuc C. The prevalence of lower urinary tract symptoms in Austrian males and associ. Eur J Epidemiol. 1999 [acceso: 23/09/2019];15(8):717-22. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/10555615

  33. Chalise PR, Agrawal CS. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate. Nepal Med Coll J. 2007 [acceso: 10/09/2019];9(4):255-8. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18298015

  34. Fernández Pérez C, Moreno Sierra J, Cano Escudero S, Fuentes Ferrer ME, Bocardo Fajardo G, Silmi Moyano Á. Prevalencia de síntomas del tracto urinario inferior relacionados con la hiperplasia benigna de próstata. Estudio de 1804 hombres de 40 años o más residentes en Madrid durante 1999-2000. Actas Urológicas Españolas. 2009 [acceso: 23/09/2019];33(1):43-51. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062009000100009

  35. Speakman MJ, Kirby RS, Joyce A, Abrams P, Pocock R. Guideline for the primary care management of male lower urinary tract symptoms. BJU Int. 2004;93(7):985-90. DOI: http://doi.wiley.com/10.1111/j.1464-410X.2004.04765.x




2020     |     www.medigraphic.com